NRNP 6635 FINAL EXAM WEEK 11 WALDEN UNIVERSITY QUESTIONS
AND ANSWERS ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains:
Psychiatric Assessment and Diagnostic Reasoning
Psychopharmacology and Medication Management
Psychotherapy and Therapeutic Interventions
Ethical and Legal Issues in Psychiatric-Mental Health Nursing
Neurobiology and Pathophysiology of Mental Disorders
Evidence-Based Practice in Psychiatric Nursing
Cultural Competence and Health Disparities
Crisis Intervention and Suicide Prevention
Addiction and Substance Use Disorders
Interprofessional Collaboration and Continuum of Care
Introduction:
,This comprehensive examination is designed to evaluate the advanced practice psychiatric-mental health nursing
student's mastery of essential knowledge and clinical skills required for competent practice. The exam assesses
foundational understanding of psychiatric disorders, psychopharmacology, psychotherapeutic modalities, and the
integration of neurobiological principles into clinical decision-making. Through a combination of multiple-choice
questions and clinical scenarios, students will demonstrate their ability to synthesize complex psychiatric
presentations, prioritize interventions, and apply evidence-based practices. Emphasis is placed on ethical and legal
considerations, cultural sensitivity, crisis management, and collaborative care approaches essential for optimizing
mental health outcomes across diverse patient populations.
SECTION ONE: QUESTIONS 1–100
Question 1
A 34-year-old female presents with persistent sadness, anhedonia, fatigue, and feelings of worthlessness for the
past six weeks. She reports difficulty concentrating and has lost 10 pounds unintentionally. Which of the
following is the most appropriate initial screening tool for this patient?
A. Hamilton Depression Rating Scale
B. Patient Health Questionnaire-9
C. Beck Depression Inventory
D. Montgomery-Åsberg Depression Rating Scale
,🟢 B. Patient Health Questionnaire-9
🔴 RATIONALE: The PHQ-9 is a validated, brief, self-administered screening tool that aligns with DSM-5 criteria
for major depressive disorder. It is practical for primary care and psychiatric settings. The Hamilton Depression
Rating Scale (A) and Montgomery-Åsberg (D) are clinician-administered and time-intensive. Beck Depression
Inventory (C) is also self-report but requires purchase and scoring training.
Question 2
A 28-year-old male with schizophrenia has been stable on risperidone 4 mg daily. He now presents with severe
muscle rigidity, fever, diaphoresis, and elevated creatine kinase. Which of the following is the most likely
diagnosis?
A. Serotonin syndrome
B. Neuroleptic malignant syndrome
C. Extrapyramidal symptoms
D. Tardive dyskinesia
🟢 B. Neuroleptic malignant syndrome
🔴 RATIONALE: Neuroleptic malignant syndrome is a life-threatening adverse reaction to antipsychotics
characterized by muscle rigidity, hyperthermia, autonomic instability, and elevated creatine kinase. Serotonin
syndrome (A) typically presents with hyperreflexia and clonus. Extrapyramidal symptoms (C) include dystonia
and akathisia without fever. Tardive dyskinesia (D) involves involuntary movements.
, Question 3
A 45-year-old patient with generalized anxiety disorder is prescribed buspirone. Which of the following is the
most important patient education point regarding this medication?
A. It may cause sedation and should be taken at bedtime
B. Therapeutic effects may take 2-4 weeks to develop
C. It should be taken on an empty stomach
D. It has a high potential for dependence
🟢 B. Therapeutic effects may take 2-4 weeks to develop
🔴 RATIONALE: Buspirone has a delayed onset of action, requiring 2-4 weeks for therapeutic effect. Unlike
benzodiazepines, it does not cause sedation (A) or dependence. It should be taken consistently with or without
food (C). It has minimal abuse potential (D).
Question 4
A 19-year-old college student presents with symptoms of inattention, distractibility, and difficulty completing
assignments. She reports these symptoms have been present since childhood. Which of the following
medications is a first-line treatment for attention-deficit/hyperactivity disorder?
A. Bupropion
B. Atomoxetine
AND ANSWERS ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains:
Psychiatric Assessment and Diagnostic Reasoning
Psychopharmacology and Medication Management
Psychotherapy and Therapeutic Interventions
Ethical and Legal Issues in Psychiatric-Mental Health Nursing
Neurobiology and Pathophysiology of Mental Disorders
Evidence-Based Practice in Psychiatric Nursing
Cultural Competence and Health Disparities
Crisis Intervention and Suicide Prevention
Addiction and Substance Use Disorders
Interprofessional Collaboration and Continuum of Care
Introduction:
,This comprehensive examination is designed to evaluate the advanced practice psychiatric-mental health nursing
student's mastery of essential knowledge and clinical skills required for competent practice. The exam assesses
foundational understanding of psychiatric disorders, psychopharmacology, psychotherapeutic modalities, and the
integration of neurobiological principles into clinical decision-making. Through a combination of multiple-choice
questions and clinical scenarios, students will demonstrate their ability to synthesize complex psychiatric
presentations, prioritize interventions, and apply evidence-based practices. Emphasis is placed on ethical and legal
considerations, cultural sensitivity, crisis management, and collaborative care approaches essential for optimizing
mental health outcomes across diverse patient populations.
SECTION ONE: QUESTIONS 1–100
Question 1
A 34-year-old female presents with persistent sadness, anhedonia, fatigue, and feelings of worthlessness for the
past six weeks. She reports difficulty concentrating and has lost 10 pounds unintentionally. Which of the
following is the most appropriate initial screening tool for this patient?
A. Hamilton Depression Rating Scale
B. Patient Health Questionnaire-9
C. Beck Depression Inventory
D. Montgomery-Åsberg Depression Rating Scale
,🟢 B. Patient Health Questionnaire-9
🔴 RATIONALE: The PHQ-9 is a validated, brief, self-administered screening tool that aligns with DSM-5 criteria
for major depressive disorder. It is practical for primary care and psychiatric settings. The Hamilton Depression
Rating Scale (A) and Montgomery-Åsberg (D) are clinician-administered and time-intensive. Beck Depression
Inventory (C) is also self-report but requires purchase and scoring training.
Question 2
A 28-year-old male with schizophrenia has been stable on risperidone 4 mg daily. He now presents with severe
muscle rigidity, fever, diaphoresis, and elevated creatine kinase. Which of the following is the most likely
diagnosis?
A. Serotonin syndrome
B. Neuroleptic malignant syndrome
C. Extrapyramidal symptoms
D. Tardive dyskinesia
🟢 B. Neuroleptic malignant syndrome
🔴 RATIONALE: Neuroleptic malignant syndrome is a life-threatening adverse reaction to antipsychotics
characterized by muscle rigidity, hyperthermia, autonomic instability, and elevated creatine kinase. Serotonin
syndrome (A) typically presents with hyperreflexia and clonus. Extrapyramidal symptoms (C) include dystonia
and akathisia without fever. Tardive dyskinesia (D) involves involuntary movements.
, Question 3
A 45-year-old patient with generalized anxiety disorder is prescribed buspirone. Which of the following is the
most important patient education point regarding this medication?
A. It may cause sedation and should be taken at bedtime
B. Therapeutic effects may take 2-4 weeks to develop
C. It should be taken on an empty stomach
D. It has a high potential for dependence
🟢 B. Therapeutic effects may take 2-4 weeks to develop
🔴 RATIONALE: Buspirone has a delayed onset of action, requiring 2-4 weeks for therapeutic effect. Unlike
benzodiazepines, it does not cause sedation (A) or dependence. It should be taken consistently with or without
food (C). It has minimal abuse potential (D).
Question 4
A 19-year-old college student presents with symptoms of inattention, distractibility, and difficulty completing
assignments. She reports these symptoms have been present since childhood. Which of the following
medications is a first-line treatment for attention-deficit/hyperactivity disorder?
A. Bupropion
B. Atomoxetine
